Compound information
- Natural Products
- ZC1561287
- Molecular Formula
- C15H20BrFN2O4S
- Molecular Weight
- 422.03111844 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-bromo-2-fluoro-phenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H20BrFN2O4S/c1-15(2,3)23-14(20)18-6-8-19(9-7-18)24(21,22)13-5-4-11(16)10-12(13)17/h4-5,10H,6-9H2,1-3H3
- InChI Key
- KJIIGGDRZPNWLW-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccc(Br)cc2F)CC1
- Source
- ZINC000148733525
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.333 |
LogS | -4.466 | LogD | 3.716 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.357 | Pgp substrate | 0.011 |
HIA | 0.975 | F20 % | 0.993 |
F30 % | 0.979 | Caco-2 | -4.503 |
MDCK | -4.934 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.953 | PPB | 98.079 |
VD | 2.828 | Fu | 0.748 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.271 | CYP1A2 substrate | 0.576 |
CYP2A6 substrate | 0.659 | CYP2B6 substrate | 0.726 |
CYP2C19 inhibitor | 0.968 | CYP2C19 substrate | 0.784 |
CYP2C8 substrate | 0.643 | CYP2C9 inhibitor | 0.666 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.338 |
CYP2D6 substrate | 0.711 | CYP2E1 substrate | 0.751 |
CYP3A4 inhibitor | 0.223 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.326 | CL | 6.331 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.61 | Hepatotoxicity | 1.0 |
Mutagenicity | 0.885 | Rat Oral Acute Toxicity | 0.235 |
FDAMDD | 0.206 | Skin Sensitization | 0.3 |
Carcinogenicity | 0.984 | Eye Corrosion | 0.082 |
Eye Irritation | 0.038 | Respiratory Toxicity | 0.812 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.646 | IGC50 | 4.043 |
LC50FM | 3.154 | LC50DM | 4.64 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.244 | NR-AR-LBD | 0.312 |
NR-AhR | 0.031 | NR-Aromatase | 0.689 |
NR-ER | 0.248 | NR-ER-LBD | 0.413 |
NR-PPAR-gamma | 0.132 | SR-ARE | 0.748 |
SR-ATAD5 | 0.383 | SR-HSE | 0.073 |
SR-MMP | 0.026 | SR-p53 | 0.033 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.